News | Brachytherapy Systems, Women's Healthcare | August 07, 2015

Theragenics to Distribute AccuBoost Technology for Early Stage Breast Cancer Treatment

Non-invasive brachytherapy treatment from Advanced Radiation Therapy supplements breast conservation therapy

Theragenics, Advanced Radiation Therapy LLC, AccuBoost, early stage breast cancer, brachytherapy

August 7, 2015 — Theragenics Corp. has reached an agreement with Advanced Radiation Therapy LLC to distribute the AccuBoost technology for the treatment of early stage breast cancer. The AccuBoost technology, developed by Advanced Radiation Therapy of Tyngsboro, Massachusetts, is used to provide a radiation “boost” following a lumpectomy. A radiation boost to the lumpectomy cavity margin as part of breast conservation therapy is the standard of care to minimize cancer recurrence. AccuBoost is also used as a non-invasive option for accelerated partial breast irradiation (APBI), a form of primary radiation therapy following lumpectomy. Under the agreement Theragenics is the exclusive third-party distributor of AccuBoost in the United States.

The technology’s real-time mammographic imaging provides advantages over other methods of delivering a radiation boost by allowing the physician to visualize the tumor bed and define the appropriate margin to target as the treatment is given. The ability to precisely target the radiation dose minimizes exposure to surrounding tissue and organs such as the heart and lungs. Use of AccuBoost may also result in improved cosmetic outcomes as compared with other methods of delivering a radiation boost.

For more information: www.theragenics.com

Related Content

 Mammography doctor
News | Breast Imaging | November 12, 2019
November 12, 2019 — Geisinger has partnered with...
Kubtec has made the Marcum Tech Top 40 (TT40) list of fastest growing technology companies in Connecticut
News | Radiology Business | November 06, 2019
November 6, 2019 — The Connecticut Technology Council (CTC) and...
Liver cancer tumor scanning using an MRI
News | Proton Therapy | November 04, 2019
November 4, 2019 – Two new studies support and inform the use of proton radiation therapy to treat patients with hepa
The U.S. market is unique in that it formed over 55 percent of the global market in 2018

The U.S. market is unique in that it formed over 55 percent of the global market in 2018.

Feature | Mammography | October 30, 2019 | By Imogen Fitt
When breast imaging comes to mind, mammography is the undisputed current modality of choice.
2-D mole marker

2-D mole marker used in 3-D, Slice 1 of 59

Sponsored Content | Case Study | Breast Imaging | October 30, 2019
When it comes to the use of mammography skin markers in dig...
Breast Tomosynthesis Increases Cancer Detection Over Digital Mammography
News | Mammography | October 23, 2019
Screening digital breast tomosynthesis (DBT) results in “significantly increased CDR [cancer detection rates]” compared...
Advanced Radiation Therapy Upgrades AccuBoost Digital Brachytherapy Platform
News | Brachytherapy Systems, Women's Healthcare | October 23, 2019
At the 2019 American Society for Radiation Oncology (ASTRO) annual meeting, Sept. 15-18 in Chicago, Advanced Radiation...